Transaction Update and General Meeting Update
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Little Green Pharma Ltd. has provided an update regarding its proposed acquisition of Cannatrek Ltd. and the upcoming general meeting for shareholders. The filing discusses the ongoing regulatory investigation involving Cannatrek and the anticipated civil penalty related to historical advertising practices. Shareholders will vote on the issuance of new shares in connection with the acquisition at the general meeting scheduled for late May. The company emphasizes that all proxy votes remain valid and encourages shareholders to participate virtually in the meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Little Green Pharma Ltd. on 6ix
In the deck
Earlier from Little Green Pharma
- Updated second court date and indicative timetable
- Scheme Update
- Scheme Approved by Cannatrek Shareholders
- Supplementary Scheme Booklet
- Termination of proposed sale and leaseback transaction
Later from Little Green Pharma
- Appendix 4E and 2026 Annual Report
- Court Approves the Scheme and Scheme Becomes Effective
- Implementation of Merger between LGP and Cannatrek
- Quarterly Activities/Appendix 4C Cash Flow Report
Follow Little Green Pharma into a list and get an email when it puts out news.
Follow Little Green Pharma